- Home
- IMRN vs SHFS Comparison
IMRN vs SHFS Comparison
Compare IMRN & SHFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- SHFS
- Stock Information
- Founded
- IMRN 1994
- SHFS 2015
- Country
- IMRN Australia
- SHFS United States
- Employees
- IMRN N/A
- SHFS N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- SHFS Finance: Consumer Services
- Sector
- IMRN Health Care
- SHFS Finance
- Exchange
- IMRN Nasdaq
- SHFS Nasdaq
- Market Cap
- IMRN 9.2M
- SHFS 9.4M
- IPO Year
- IMRN N/A
- SHFS N/A
- Fundamental
- Price
- IMRN $1.92
- SHFS $7.22
- Analyst Decision
- IMRN Strong Buy
- SHFS
- Analyst Count
- IMRN 1
- SHFS 0
- Target Price
- IMRN $5.00
- SHFS N/A
- AVG Volume (30 Days)
- IMRN 41.7K
- SHFS 2.2M
- Earning Date
- IMRN 08-29-2025
- SHFS 11-11-2025
- Dividend Yield
- IMRN N/A
- SHFS N/A
- EPS Growth
- IMRN N/A
- SHFS N/A
- EPS
- IMRN N/A
- SHFS N/A
- Revenue
- IMRN $4,777,422.00
- SHFS $11,720,493.00
- Revenue This Year
- IMRN N/A
- SHFS N/A
- Revenue Next Year
- IMRN N/A
- SHFS N/A
- P/E Ratio
- IMRN N/A
- SHFS N/A
- Revenue Growth
- IMRN 48.63
- SHFS N/A
- 52 Week Low
- IMRN $1.50
- SHFS $1.84
- 52 Week High
- IMRN $2.87
- SHFS $11.74
- Technical
- Relative Strength Index (RSI)
- IMRN 56.80
- SHFS 79.30
- Support Level
- IMRN $1.85
- SHFS $3.07
- Resistance Level
- IMRN $1.94
- SHFS $3.37
- Average True Range (ATR)
- IMRN 0.08
- SHFS 0.61
- MACD
- IMRN 0.00
- SHFS 0.15
- Stochastic Oscillator
- IMRN 86.67
- SHFS 67.78
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring, among others.